TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
-1.48%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$382M
AUM Growth
+$382M
(+16%)
Cap. Flow
+$58.1M
Cap. Flow
% of AUM
15.22%
Top 10 Holdings %
Top 10 Hldgs %
74.12%
Holding
33
New
8
Increased
11
Reduced
3
Closed
2
Top Buys
| 1 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$11.9M |
| 2 |
Zimmer Biomet
ZBH
|
$9.61M |
| 3 |
Integer Holdings
ITGR
|
$8.69M |
| 4 |
HMSY
HMS Holdings Corp.
HMSY
|
$7.76M |
| 5 |
United Therapeutics
UTHR
|
$5.98M |
Top Sells
| 1 |
Haemonetics
HAE
|
$12.1M |
| 2 |
NovoCure
NVCR
|
$9.64M |
| 3 |
SRCL
Stericycle Inc
SRCL
|
$6.37M |
| 4 |
Medtronic
MDT
|
$2.17M |
| 5 |
Quest Diagnostics
DGX
|
$1.49M |
Sector Composition
| 1 | Healthcare | 86.27% |
| 2 | Industrials | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
1
DELISTED
Veradigm Inc. Common Stock
MDRX
| $46.4M | 12.09% | 4,225,000 +300,000 | +8% | +$3.29M |
|
|
2
Medtronic
MDT
$119B
| $43.4M | 11.32% | 400,000 -20,000 | -5% | -$2.17M |
|
3
Bio-Rad Laboratories Class A
BIO
$8.06B
| $38.3M | 9.97% | 115,000 +15,000 | +15% | +$4.99M |
|
4
Pacira BioSciences
PCRX
$1.2B
| $29.5M | 7.69% | 775,000 +150,000 | +24% | +$5.71M |
|
|
PTLA
5
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $26.8M | 6.99% | 1,000,000 +445,000 | +80% | +$11.9M |
|
|
6
Zimmer Biomet
ZBH
$21B
| $22M | 5.72% | 160,000 +70,000 | +78% | +$9.61M |
|
7
AtriCure
ATRC
$1.84B
| $21.2M | 5.52% | 850,000 +175,000 | +26% | +$4.36M |
|
8
Lantheus
LNTH
$3.73B
| $18.8M | 4.9% | 750,000 +20,000 | +3% | +$501K |
|
|
9
Quest Diagnostics
DGX
$20.3B
| $18.7M | 4.88% | 175,000 -13,900 | -7% | -$1.49M |
|
|
SRCL
10
DELISTED
Stericycle Inc
SRCL
| $17.8M | 4.64% | 350,000 -125,000 | -26% | -$6.37M |
|
11
Hologic
HOLX
$14.9B
| $14.1M | 3.68% | 280,000 +5,000 | +2% | +$252K |
|
12
Rigel Pharmaceuticals
RIGL
$697M
| $10.2M | 2.67% | 5,475,000 | – | – |
|
|
CMD
13
DELISTED
Cantel Medical Corporation
CMD
| $10.1M | 2.63% | 135,000 +20,000 | +17% | +$1.5M |
|
|
CORV
14
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $9M | 2.35% | 4,500,000 +1,150,000 | +34% | +$2.3M |
|
|
15
Integer Holdings
ITGR
$3.78B
| $8.69M | 2.26% | +115,000 | New | +$8.69M |
|
|
HMSY
16
DELISTED
HMS Holdings Corp.
HMSY
| $7.76M | 2.02% | +225,000 | New | +$7.76M |
|
|
17
United Therapeutics
UTHR
$13.8B
| $5.98M | 1.56% | +75,000 | New | +$5.98M |
|
18
ICU Medical
ICUI
$3.15B
| $5.59M | 1.46% | +35,000 | New | +$5.59M |
|
19
Phreesia
PHR
$1.88B
| $4.85M | 1.26% | +200,000 | New | +$4.85M |
|
|
OPTN
20
DELISTED
OptiNose
OPTN
| $4.73M | 1.23% | +675,000 | New | +$4.73M |
|
21
RadNet
RDNT
$5.52B
| $4.67M | 1.22% | +325,000 | New | +$4.67M |
|
|
NVRO
22
DELISTED
NEVRO CORP.
NVRO
| $4.55M | 1.18% | 52,864 +2,864 | +6% | +$246K |
|
|
ISEE
23
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.36M | 0.88% | 3,000,000 | – | – |
|
|
GWPH
24
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.88M | 0.75% | +25,000 | New | +$2.88M |
|
|
STRM
25
DELISTED
Streamline Health Solutions
STRM
| $2.28M | 0.59% | 2,100,000 | – | – |
|